A carregar...
Publicação
Bausch + lomb company valuation - estimating valuation multiples based on multiple regressions
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.16 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This work project conducts a company valuation of Bausch + Lomb and evaluates
different exit options for the company. The individual part consists of a valuation based on a
multiple regression approach. The group part consists of Bausch + Lomb’s valuation based on
a discounted cash flow model (DCF) and relative valuation approaches. Considering the DCF
model, B + L’s enterprise value is estimated at $7,325 mn as of 31/12/202
Descrição
Palavras-chave
Bausch + lomb Company valuation Acquisition Pharamceuticals Eye care